Incidence of Hepatic Hemangiomatosis in Patients With Cutaneous Hemangiomas

NCT00374335 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 261

Last updated 2011-09-16

Study results available
· View outcomes & findings →

Summary

This study will attempt to determine how common liver hemangiomas are in children with infantile hemangiomas by comparing liver ultrasound results in patients with 1-4 cutaneous hemangiomas, 5 or more cutaneous hemangiomas, or at least 1 large hemangioma versus ultrasound results in children without hemangiomas. Other objectives of the study include identifying specific risk factors in patients who have liver hemangiomas and identifying risk factors in children with symptomatic liver hemangiomas.

Conditions

  • Hemangioma

Interventions

PROCEDURE

abdominal ultrasound

abdominal ultrasound to detect hepatic hemangiomas

OTHER

Dermatologic Examination

Complete dermatologic examination

Sponsors & Collaborators

  • Medical College of Wisconsin

    collaborator OTHER
  • University of California, San Francisco

    collaborator OTHER
  • Columbia University

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • Northwestern University

    collaborator OTHER
  • St. Justine's Hospital

    collaborator OTHER
  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    collaborator OTHER
  • Children's Mercy Hospital Kansas City

    lead OTHER

Principal Investigators

  • Beth A Drolet, MD · Medical College of Wisconsin

  • Maria Garzon, MD · Columbia University

  • Kimberly A Horii, MD · Children's Mercy Hospital Kansas City

  • Denise Metry, MD · Baylor College of Medicine

  • Sarah Chamlin, MD · Northwestern University-Children's Memorial Hospital

  • Ilona J Frieden, MD · University of California, San Francisco

  • Julie Powell, MD · St. Justine's Hospital

  • Anne Lucky, MD · Children's Hospital of Cincinnati

  • Eulalia Baselga, MD · Hospital de la Santa Crue i Santa Pau

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2008-06-30
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374335 on ClinicalTrials.gov